Ray Dalio's HOLX Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 13,448 shares of Hologic, Inc. (HOLX) worth $1 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in HOLX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 246,407 shares. Largest reduction occurred in Q4 2022, reducing 153,339 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Hologic (HOLX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Hologic (HOLX) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -10,124 | Reduce 42.95% | 13,448 | $74.49 |
| Q3 2025 | +16,258 | Add 222.29% | 23,572 | $67.49 |
| Q2 2025 | -24,557 | Reduce 77.05% | 7,314 | $65.16 |
| Q1 2025 | -21,926 | Reduce 40.76% | 31,871 | $61.77 |
| Q4 2024 | -111,030 | Reduce 67.36% | 53,797 | $72.09 |
| Q3 2024 | -152,507 | Reduce 48.06% | 164,827 | $81.46 |
| Q2 2024 | +8,091 | Add 2.62% | 317,334 | $74.25 |
| Q1 2024 | -115,093 | Reduce 27.12% | 309,243 | $77.96 |
| Q4 2023 | -96,857 | Reduce 18.58% | 424,336 | $71.45 |
| Q3 2023 | +33,381 | Add 6.84% | 521,193 | $69.40 |
| Q2 2023 | -56,579 | Reduce 10.39% | 487,812 | $80.97 |
| Q1 2023 | +98,331 | Add 22.04% | 544,391 | $80.70 |
| Q4 2022 | -153,339 | Reduce 25.58% | 446,060 | $74.81 |
| Q3 2022 | -39,235 | Reduce 6.14% | 599,399 | $64.52 |
| Q2 2022 | +246,407 | Add 62.82% | 638,634 | $69.30 |
| Q1 2022 | +90,017 | Add 29.79% | 392,227 | $76.82 |
| Q4 2021 | +16,128 | Add 5.64% | 302,210 | $76.56 |
| Q3 2021 | -23,667 | Reduce 7.64% | 286,082 | $73.81 |
| Q2 2021 | +129,050 | Add 71.42% | 309,749 | $66.72 |
| Q1 2021 | +25,978 | Add 16.79% | 180,699 | $74.38 |
| Q4 2020 | +90,375 | Add 140.45% | 154,721 | $72.83 |
| Q3 2020 | +64,346 | New Buy | 64,346 | $66.47 |
| Q1 2019 | -34,277 | Sold Out | 0 | $0.00 |
| Q4 2018 | +34,277 | New Buy | 34,277 | $41.11 |
| Q2 2018 | -20,164 | Sold Out | 0 | $0.00 |
| Q1 2018 | +20,164 | New Buy | 20,164 | $37.34 |
| Q2 2016 | -52,900 | Sold Out | 0 | $0.00 |
| Q1 2016 | +52,900 | New Buy | 52,900 | $34.50 |
| Q3 2013 | -43,800 | Sold Out | 0 | $0.00 |
| Q2 2013 | +43,800 | Add 0.00% | 43,800 | $19.29 |
Ray Dalio's Hologic Investment FAQs
Ray Dalio first purchased Hologic, Inc. (HOLX) in Q2 2013, acquiring 43,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Hologic, Inc. (HOLX) for 30 quarters since Q2 2013.
Ray Dalio's largest addition to Hologic, Inc. (HOLX) was in Q2 2022, adding 638,634 shares worth $44.26 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 13,448 shares of Hologic, Inc. (HOLX), valued at approximately $1 M.
As of the Q4 2025 filing, Hologic, Inc. (HOLX) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Hologic, Inc. (HOLX) was 638,634 shares, as reported at the end of Q2 2022.